| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bladder cancer risk from occupational and environmental exposures
|
Kiriluk, Kyle J.
|
|
2012
|
30 |
2 |
p. 199-211
13 p.
|
artikel
|
| 2 |
Commentary on “Association between smoking and risk of bladder cancer among men and women.” Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD
|
See, William
|
|
2012
|
30 |
2 |
p. 231-232
2 p.
|
artikel
|
| 3 |
Commentary on “Diabetes and risk of bladder cancer: Evidence from a case-control study in New England.” MacKenzie T, Zens MS, Ferrara A, Schned A, Karagas MR, Department of Medicine, Dartmouth Medical School, Hanover, NH
|
See, William
|
|
2012
|
30 |
2 |
p. 230-231
2 p.
|
artikel
|
| 4 |
Commentary on “DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer.” Marsit CJ, Koestler DC, Christensen BC, Karagas MR, Houseman EA, Kelsey KT, Pathology and Laboratory Medicine, Brown University, Providence, RI
|
See, William
|
|
2012
|
30 |
2 |
p. 230-
1 p.
|
artikel
|
| 5 |
Commentary on “Dynamic real-time microscopy of the urinary tract using confocal laser endomicroscopy.” Wu K, Liu JJ, Adams W, Sonn GA, Mach KE, Pan Y, Beck AH, Jensen KC, Liao JC, Department of Urology, Stanford Cancer Center, Stanford University School of Medicine, Stanford, CA
|
See, William
|
|
2012
|
30 |
2 |
p. 229-230
2 p.
|
artikel
|
| 6 |
Commentary on “International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: Long-term results of the BA06 30894 trial.” Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK, and the International Collaboration of Trialists; Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group); European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group; Australian Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; Finnbladder; Norwegian Bladder Cancer Study Group; Club Urologico Espanol de Tratamiento Oncologico Group. Medical Research Council Clinical Trials Unit, London, United Kingdom
|
Grossman, H. Barton
|
|
2012
|
30 |
2 |
p. 226-
1 p.
|
artikel
|
| 7 |
Commentary on “Long-term use of supplemental vitamins and minerals does not reduce the risk of urothelial cell carcinoma of the bladder in the VITamins And Lifestyle study.” Hotaling JM, Wright JL, Pocobelli G, Bhatti P, Porter MP, White E, Department of Urology, University of Washington School of Medicine, Seattle, Washington 98103, USA
|
Grossman, H. Barton
|
|
2012
|
30 |
2 |
p. 226-227
2 p.
|
artikel
|
| 8 |
Commentary on “Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy.” Lu Z, Yeh TK, Wang J, Chen L, Lyness G, Xin Y, Wientjes MG, Bergdall V, Couto G, Alvarez-Berger F, Kosarek CE, Au JL, Optimum Therapeutics, L.L.C., Columbus, OH
|
Grossman, H. Barton
|
|
2012
|
30 |
2 |
p. 228-
1 p.
|
artikel
|
| 9 |
Commentary on “Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04–75.” Hahn NM, Stadler WM, Zon RT, Waterhouse D, Picus J, Nattam S, Johnson CS, Perkins SM, Waddell MJ, Sweeney CJ; Hoosier Oncology Group, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN
|
Grossman, H. Barton
|
|
2012
|
30 |
2 |
p. 228-229
2 p.
|
artikel
|
| 10 |
Commentary on “Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancer.” Zlotta AR, Roumeguere T, Kuk C, Alkhateeb S, Rorive S, Lemy A, van der Kwast TH, Fleshner NE, Jewett MA, Finelli A, Schulman C, Lotan Y, Shariat SF, Nortier J, Division of Urology, Mount Sinai Hospital, Toronto, Canada
|
Grossman, H. Barton
|
|
2012
|
30 |
2 |
p. 229-
1 p.
|
artikel
|
| 11 |
Commentary on “Trends in hospital volume and operative mortality for high-risk surgery.” Finks JF, Osborne NH, Birkmeyer JD, Center for Healthcare Outcomes and Policy and the Section of General Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI
|
Grossman, H. Barton
|
|
2012
|
30 |
2 |
p. 227-
1 p.
|
artikel
|
| 12 |
Commentary on “25 years of experience with 1,000 neobladders: Long-term complications.” Hautmann RE, de Petriconi RC, Volkmer BG, Department of Urology, University of Ulm, Ulm, Germany
|
See, William
|
|
2012
|
30 |
2 |
p. 232-
1 p.
|
artikel
|
| 13 |
Contents
|
|
|
2012
|
30 |
2 |
p. vi-vii
nvt p.
|
artikel
|
| 14 |
Dutasteride monotherapy in men with serologic relapse following radical therapy for adenocarcinoma of the prostate: A pilot study
|
Perrotti, Michael
|
|
2012
|
30 |
2 |
p. 133-138
6 p.
|
artikel
|
| 15 |
Editorial Board
|
|
|
2012
|
30 |
2 |
p. v-
1 p.
|
artikel
|
| 16 |
Environmental and modifiable risk factors in renal cell carcinoma
|
Navai, Neema
|
|
2012
|
30 |
2 |
p. 220-224
5 p.
|
artikel
|
| 17 |
Environmental exposures and genitourinary malignancies
|
Smith, Norm D.
|
|
2012
|
30 |
2 |
p. 196-198
3 p.
|
artikel
|
| 18 |
Environmental exposures and prostate cancer
|
Mullins, Jeffrey K.
|
|
2012
|
30 |
2 |
p. 216-219
4 p.
|
artikel
|
| 19 |
Environmental toxicology of testicular cancer
|
Meeks, Joshua J.
|
|
2012
|
30 |
2 |
p. 212-215
4 p.
|
artikel
|
| 20 |
Erratum to the January/February 2012 issue
|
|
|
2012
|
30 |
2 |
p. 233-
1 p.
|
artikel
|
| 21 |
Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma
|
Wang, Zhi Yu
|
|
2012
|
30 |
2 |
p. 167-176
10 p.
|
artikel
|
| 22 |
Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection
|
Muramaki, Mototsugu
|
|
2012
|
30 |
2 |
p. 161-166
6 p.
|
artikel
|
| 23 |
Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection
|
Lin, Hui-Hui
|
|
2012
|
30 |
2 |
p. 177-181
5 p.
|
artikel
|
| 24 |
Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract
|
Scarpini, Sylvia
|
|
2012
|
30 |
2 |
p. 182-187
6 p.
|
artikel
|
| 25 |
111-In-capromab pendetide imaging using hybrid-γ camera-computer tomography technology is not reliable in detecting seminal vesicle invasion in patients with prostate cancer
|
Tsivian, Matvey
|
|
2012
|
30 |
2 |
p. 150-154
5 p.
|
artikel
|
| 26 |
Information for Authors
|
|
|
2012
|
30 |
2 |
p. IBC-
1 p.
|
artikel
|
| 27 |
Masthead
|
|
|
2012
|
30 |
2 |
p. iv-
1 p.
|
artikel
|
| 28 |
Outcome prediction for prostate cancer detection rate with artificial neural network (ANN) in daily routine
|
Ecke, Thorsten H.
|
|
2012
|
30 |
2 |
p. 139-144
6 p.
|
artikel
|
| 29 |
Perspectives on personalized cancer care
|
Dancik, Garrett M.
|
|
2012
|
30 |
2 |
p. 121-125
5 p.
|
artikel
|
| 30 |
Prostate specific antigen screening for prostate cancer: Knowledge of, attitudes towards, and utilization among primary care physicians
|
Tasian, Gregory E.
|
|
2012
|
30 |
2 |
p. 155-160
6 p.
|
artikel
|
| 31 |
Significant activity of single agent vinorelbine against small-cell cancer of the bladder as second line chemotherapy: A case series and review of the literature
|
June, Rayford R.
|
|
2012
|
30 |
2 |
p. 192-195
4 p.
|
artikel
|
| 32 |
Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: An overview
|
Scosyrev, Emil
|
|
2012
|
30 |
2 |
p. 126-132
7 p.
|
artikel
|
| 33 |
Survey Section Editorial Board
|
|
|
2012
|
30 |
2 |
p. 225-
1 p.
|
artikel
|
| 34 |
Testicular sparing surgery for small masses
|
Shilo, Yaniv
|
|
2012
|
30 |
2 |
p. 188-191
4 p.
|
artikel
|
| 35 |
Tumor cytoreduction results in better response to androgen ablation—a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer
|
Qin, Xiao-Jian
|
|
2012
|
30 |
2 |
p. 145-149
5 p.
|
artikel
|
|
Tijdschrift beschrijving